Angiosarcoma (hepatic)

Hepatic angiosarcoma (HA) is a particularly rare, non-cirrhotic, primary malignancy of the liver, accounting for 2% of liver cancers [1]. However, it is still considered to be the third most common primary hepatic malignancy. HA is a high-grade, aggressive tumor. Surgery is the primary method of treatment for angiosarcoma. Chemotherapy and/or radiation therapy can be an important part of the treatment plan, and they may be administered before or after surgery. The chemotherapy of choice for angiosarcomas has been doxorubicin, and some centers use a combination of mesna, doxorubicin, and ifosfamide (MAI). Liposomal Doxorubicin has also been utilized. Paclitaxel and Docetaxel have shown effectiveness against angiosarcomas of the head, neck and scalp.

Source
Source

Known Toxin and Potential effects
Strong Good Limited
Known Toxin and Potential effects - Copper -
Cheyenne, United States
McGuire Air Force Base, United States
Atwater, United States
Bremerton, United States
Portsmouth, United States
Newport News, United States
Parris Island, United States
Warminster, United States
Umatilla, United States
Jacksonville, United States
Plattsburgh, United States
Newington, United States
Oscoda, United States
Devens, United States
Weymouth, United States
Hanscom Air Force Base, United States
Patuxent River, United States
Aberdeen Proving Ground, United States
Baltimore, United States
Kittery, United States
Brunswick, United States
Limestone, United States
Mountain Home Air Force Base, United States
Joint Base Pearl Harbor-Hickam, United States
Milton, United States
Pensacola, United States
Jacksonville, United States
Homestead, United States
Fairfield, United States
Mountain View, United States
Camp Pendleton North, United States
Victorville, United States
Mather, United States
Concord, United States
San Bernardino, United States
Yuma, United States